Is the A2 Milk (ASX:A2M) share price cheap? Here's what brokers think

The A2 Milk Company Ltd (ASX:A2M) share price is down 70% from its 52-week high. Is this a buying opportunity for investors?

On Monday the A2 Milk Company Ltd (ASX: A2M) share price continued its disappointing run with another sizeable decline.

The fresh milk and infant formula company's shares plunged 13% to $6.10.

This means the a2 Milk share price is now down a whopping 70% from its 52-week high.

A woman with black afro hair and wearing a white t-shirt shrugs and purses her lips

Image source: Getty Images

Why did the a2 Milk share price crash lower?

Investors were selling the company's shares on Monday after it downgraded its FY 2021 guidance for a fourth time.

Back in August 2020, a2 Milk was guiding to "strong revenue growth" on the NZ$1.73 billion it achieved in FY 2020 and an EBITDA margin of 30% to 31%.

Whereas management now expects revenue of NZ$1.2 billion to NZ$1.25 billion with an EBITDA margin of 11% to 12%. This implies EBITDA of just NZ$132 million to NZ$150 million, which will be down 73% to 76% year on year.

What do brokers think?

Given the significant weakness in the a2 Milk share price, investors will no doubt be wondering whether its shares are cheap now. Well, opinion is divided in the broker community.

One broker that doesn't think its shares are cheap is Credit Suisse. This morning the broker retained its underperform rating and cut its price target to $5.00. It estimates that its shares are changing hands for 34x FY 2022 earnings at present.

Macquarie Group Ltd (ASX: MQG) is also bearish. It downgraded its shares to an underperform rating and cut the price target on them to $5.60.

As is Citi, which has retained its sell rating and cut its price target to $5.85.

Morgans is a little more positive. It has retained its hold rating but slashed its price target to $6.65. Based on its forecasts, it estimates that its shares are trading at 26x FY 2022 earnings.

Elsewhere, Bell Potter has retained its buy rating and cut its price target to $8.50, Morgan Stanley has a $7.10 price target, and UBS has a buy rating and lofty NZ$13.50 (A$12.52) price target. All three targets offer meaningful upside from the current a2 Milk share price of $6.10.

In respect to the latter note, UBS believes the actions management is taking will restore inventory to healthy levels by the first quarter of FY 2022. It appears optimistic that this will avoid any brand damage.

Time will tell which broker makes the right call.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Smiling woman taking a video through a plane window with her phone.
Broker Notes

Qantas or Virgin shares. Which ASX airline has more upside?

Will either share take off soon?

Read more »

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »